What Companies Are at Bio Innovations North America 2026?

Twelve develops technology that transforms captured carbon dioxide into fuels, chemicals, and materials using renewable electricity.

The company is commercializing its carbon transformation technology at industrial scale, including sustainable aviation fuel production. Its approach connects renewable energy, carbon utilization, and next-generation industrial manufacturing.

eXoZymes develops cell-free biomanufacturing technology that uses engineered enzymes to produce chemicals and other molecules without relying on living cells.

Cell-free systems can give manufacturers more direct control over biological reactions while opening production pathways that may be difficult to achieve through conventional fermentation.

Cascade Bio develops biocatalysts for industrial chemical manufacturing.

Its technology uses enzymes to enable chemical reactions under more efficient conditions, helping manufacturers explore alternatives to conventional chemical processes that can require greater energy input or generate more waste.

Craft BioSolutions develops modular fermentation systems designed for the space between laboratory experiments and large-scale manufacturing.

Its platform uses single-use fermentation vessels, sensors, process controls, and modular capacity to help companies produce real batches and generate process data before committing to larger manufacturing infrastructure.

For early-stage biomanufacturing companies, that addresses a critical scale-up gap between proving biology in the lab and building or contracting full-scale production.

Ecovaleric develops technology for converting plant-derived feedstocks into biodegradable polymers and materials.

The company sits at the intersection of renewable feedstocks, chemistry, and materials manufacturing as industries search for alternatives to fossil-derived and persistent materials.

Kemvera develops catalytic technology that converts bioethanol into sustainable drop-in chemicals.

Its platform is initially focused on bio-based acetic acid and ethyl acetate, using ethanol as a renewable feedstock while maintaining compatibility with established chemical applications.

The company is building around existing ethanol infrastructure, creating another potential route from agricultural feedstocks to high-volume industrial chemicals.

Låkril Technologies develops technology for producing bio-based acrylic acid from renewable lactic acid.

Acrylic acid is an important chemical building block used across coatings, adhesives, superabsorbent materials, and other products. Låkril's approach is designed to create a renewable drop-in alternative to petroleum-derived acrylics.

The company is advancing the process toward continuous and commercial-scale production.

Oleo develops technology that transforms biomass waste into feedstocks for advanced fuels.

Its approach connects waste biomass with the growing market for lower-carbon fuel pathways, where reliable and scalable renewable feedstocks are a critical part of commercialization.

Sustainable Chemicals develops technologies for producing renewable alternatives to conventional chemical products.

The company represents the broader shift in industrial chemistry toward using biological and renewable inputs to reduce dependence on fossil-derived feedstocks.

Aerterra develops technology for industrial biotechnology and bioeconomy applications.

Its work contributes to the growing set of biological technologies being developed for commercial manufacturing and industrial use.

BioCloak develops biodegradable encapsulation technology for agricultural and animal-nutrition applications.

Its technology is designed to replace petroleum-derived encapsulation materials with bio-based alternatives while improving the delivery of active ingredients.

That connects biological innovation with a large commercial challenge: reducing persistent materials such as microplastics in agricultural systems.

BioCognito develops technology within the biotechnology and industrial bioeconomy ecosystem.

The company operates within a market increasingly focused on translating biological innovation into commercially scalable products and processes.

BioIntelligence Technologies develops real-time analytics and monitoring technology for biological manufacturing.

Its platform measures products, nutrients, and metabolic intermediates during production and applies analytics to help operators understand and optimize bioprocess performance.

Better process visibility can help manufacturers improve yields, consistency, and economics as biological production moves toward larger scale.

Biosimo develops technology that converts bioethanol into industrial platform chemicals.

Its process uses a proprietary catalyst and continuous reactor system, with bio-based acetic acid as its flagship product and additional chemicals including acetaldehyde and ethyl acetate in development.

The model is designed around standard industrial equipment, helping reduce the infrastructure barrier associated with scaling new chemical production technologies.

Canopy develops technology within the industrial biotechnology ecosystem.

Its work contributes to the broader development of biological products, processes, and infrastructure supporting the bioeconomy.

Cauldron Ferm develops continuous fermentation technology for industrial biomanufacturing.

Fermentation economics can determine whether a bio-based product becomes commercially viable. Continuous-production approaches aim to increase asset utilization, improve productivity, and reduce manufacturing costs.

That places fermentation infrastructure directly at the center of the industry's scale-up challenge.

Dakota BioWorx helps biotechnology companies move from discovery to scalable production.

Its facilities provide fermentation capacity, laboratories, pilot infrastructure, and bioprocess-development capabilities for companies producing enzymes, proteins, biomass, and other biologically manufactured products.

Organizations like Dakota BioWorx form part of the infrastructure that allows emerging biotechnology companies to scale without immediately building their own manufacturing facilities.

Decycle Bio develops sustainable chemical-production technology using cell-free biology and enzyme engineering.

Its approach is designed to convert industrial outputs into useful chemicals while avoiding some of the complexity associated with engineering entire microbial cells.

The company illustrates how cell-free systems are emerging as another manufacturing platform within industrial biotechnology.

Finish Line Bio develops technology that connects genetic changes with fermentation yield.

Its genome-to-yield platform identifies genetic edits that can increase production in microbial strains used to manufacture chemicals and proteins.

Improving strain performance is a direct lever on biomanufacturing economics because higher yields can increase output without requiring proportional increases in production capacity.

Imperagen develops a closed-loop enzyme-engineering platform combining physics-based modeling, AI, automated laboratory testing, and experimental feedback.

The platform is designed to improve enzyme activity, stability, selectivity, yield, and manufacturability while reducing the number of experimental cycles required.

More predictable enzyme engineering can help biocatalysis move faster from laboratory performance to commercially useful industrial processes.

Ketone-IQ produces drinkable ketones for energy and performance applications.

The company's ketones are produced through fermentation, connecting consumer nutrition with industrial biological production.

Its presence illustrates how biomanufacturing is reaching consumer-facing markets alongside chemicals, fuels, and industrial materials.

Kuehnle AgroSystems develops high-value natural products from microalgae for food, feed, nutraceutical, and health applications.

Its technology uses a dark-fermentation process to produce algae-derived compounds using standard fermentation equipment.

The approach demonstrates how fermentation can make biologically derived ingredients with less dependence on land, light, and conventional agricultural production.

LifeSpace Labs supports biotechnology innovators through shared infrastructure and a collaborative company ecosystem.

Organizations like LifeSpace Labs provide an enabling layer for early-stage biotechnology, helping founders and technical teams access the environments and communities needed to turn scientific ideas into companies.

Maia Farms produces mycelium-based protein ingredients through biomass fermentation.

The company combines strain development, fermentation science, process optimization, and data-driven R&D to turn fungal biology into scalable food ingredients.

Its work shows how industrial biomanufacturing is expanding into food and ingredient production alongside chemicals and materials.

miibio develops technology that uses light to control microbial metabolic pathways during biomanufacturing.

Its photoswitchable protein technology is designed to improve production yields by allowing biological processes to be controlled more precisely during manufacturing.

The company is advancing the approach toward pilot-scale production for green chemicals and other biologically manufactured products.

The Pennycress Company develops pennycress as a renewable agricultural crop and industrial feedstock.

Reliable, cost-effective feedstocks are fundamental to industrial biotechnology because biological manufacturing requires large volumes of renewable carbon as production scales.

Pennycress also creates an opportunity to connect new bio-based supply chains with existing agricultural systems.

Sustainea produces renewable monoethylene glycol and monopropylene glycol from plant-based feedstocks.

The chemicals are designed as drop-in alternatives to fossil-derived glycols used across packaging, textiles, resins, cosmetics, and other industrial applications.

Sustainea demonstrates how bio-based production can target established large-volume chemical markets without requiring customers to redesign the products that use those molecules.

Xtelligence develops protein-material technology designed to improve the production and use of difficult-to-express proteins and enzymes.

Its work focuses on enabling high-value enzymes for biocatalysis while addressing challenges including protein folding, extraction, reaction conditions, and enzyme reuse.

Those capabilities can expand the range of chemical reactions that become practical through biological catalysts.

Boston Bioprocess provides fermentation process development, optimization, and scale-up services to biotechnology companies.

For fermentation-based businesses, developing the biology is only part of the challenge. Processes must also remain productive and repeatable as they move into larger reactors.

Boston Bioprocess helps companies bridge the transition between laboratory fermentation and commercial manufacturing.

CarbonBridge develops direct-gas bioreactor technology for microbial manufacturing.

Its system brings microbes directly into contact with gaseous feedstocks, addressing mass-transfer limitations that can restrict conventional gas-fermentation systems.

The technology is designed to support scalable production of fuels, chemical intermediates, and other bio-industrial products from gaseous inputs.

Cemvita uses engineered microbes and fermentation to transform low-value carbon streams into useful products.

Its technology combines carbon capture, biological conversion, and downstream processing to create products including sustainable oils and agricultural inputs.

The company represents the broader effort to make waste carbon a manufacturing feedstock rather than simply an emission.

Fermeate develops technology designed to increase productivity in existing industrial fermentation systems.

Its platform works with microbial production across amino acids, proteins, food ingredients, specialty chemicals, flavors, and fragrances.

Improving productivity inside existing bioreactors can help manufacturers increase output without making the same increase in capital expenditure, making process efficiency a major commercialization lever.

Aropha develops biotechnology and testing capabilities for evaluating biodegradation and environmental performance.

As more companies introduce bio-based and biodegradable materials, reliable testing becomes important for understanding whether those materials actually perform as intended after use.

That gives companies developing new materials another piece of infrastructure needed for commercialization.

Terra Bioforge develops fermentation and industrial biotechnology capabilities for biological production.

The company operates within the part of the bioeconomy focused on converting laboratory biology into reproducible and scalable manufacturing processes.

What companies are at Bio Innovations North America 2026?

This page lists 34 companies participating in Bio Innovations North America 2026, including Twelve, eXoZymes, Cascade Bio, Craft BioSolutions, Ecovaleric, Kemvera, Låkril Technologies, Oleo, Sustainable Chemicals, BioIntelligence Technologies, Biosimo, Cauldron Ferm, Dakota BioWorx, Decycle Bio, Finish Line Bio, Imperagen, Kuehnle AgroSystems, Maia Farms, miibio, Sustainea, Boston Bioprocess, CarbonBridge, Cemvita, Fermeate, Aropha, Terra Bioforge, and others.

When is Bio Innovations North America 2026?

Bio Innovations North America 2026 takes place September 9–10, 2026.

Where is Bio Innovations North America 2026?

Bio Innovations North America 2026 takes place at CHI Health Center Omaha in Omaha, Nebraska.

What is Bio Innovations North America?

Bio Innovations North America is an industry event focused on commercializing and scaling industrial biomanufacturing in North America. The event brings together bio-developers and producers, chemical manufacturers, consumer brands, investors, technology providers, infrastructure companies, and other organizations across the bioeconomy.

How many companies are listed on this page?

This page lists 34 companies participating in Bio Innovations North America 2026. The wider conference connects more than 400 industry participants across the industrial bioeconomy.

How many people attend Bio Innovations North America 2026?

Bio Innovations North America connects more than 400 industry participants through conference sessions, networking, and pre-arranged 1-to-1 commercial meetings.

Which bio-based chemical companies are at Bio Innovations North America 2026?

Bio-based and renewable chemical companies include Kemvera, Låkril Technologies, Biosimo, Sustainea, Sustainable Chemicals, Twelve, Cemvita, and Ecovaleric.

Which fermentation companies are at Bio Innovations North America 2026?

Companies working across fermentation and bioprocessing include Cauldron Ferm, Fermeate, Boston Bioprocess, Terra Bioforge, Craft BioSolutions, Maia Farms, Kuehnle AgroSystems, and Dakota BioWorx.

Which biocatalysis and enzyme companies are at Bio Innovations North America 2026?

Companies working across biocatalysis and enzyme technology include Cascade Bio, eXoZymes, Imperagen, and Xtelligence. Their technologies span industrial enzymes, cell-free manufacturing, AI-guided enzyme engineering, and protein materials for biocatalysis.

Which carbon conversion companies are at Bio Innovations North America 2026?

Companies working with carbon and alternative industrial feedstocks include Twelve, Cemvita, CarbonBridge, and Decycle Bio. Their technologies explore different ways of turning CO2, gaseous feedstocks, waste carbon, and industrial outputs into fuels, chemicals, and other products.

What is the Biomanufacturing Shark Tank at Bio Innovations North America?

The Biomanufacturing Shark Tank is a startup competition held during Bio Innovations North America 2026. Six companies selected for the competition are Craft BioSolutions, Ecovaleric, Kemvera, Låkril Technologies, Oleo, and Sustainable Chemicals.

Why should sales teams track companies participating in Bio Innovations North America?

Bio Innovations North America is centered on business development and commercialization. Companies participating in the event are actively engaging with potential customers, partners, investors, technology providers, suppliers, and manufacturing resources. For teams selling into industrial biotechnology, chemicals, materials, ingredients, manufacturing, sustainability, or the wider bioeconomy, these signals help identify companies actively moving toward commercialization and scale.